Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity – May 2026 Monthly Newsletter and Success Story
Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity – May 2026 Monthly Newsletter and Success Story

We invite you to read the May 2026 Newsletter of the Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity, funded by the U.S. Government. We are also pleased to share a new SAFEMed success story, From Data to Action: How SAFEMed Supports Hospital Decision-Making in Ukraine.
In this issue, you’ll find the following stories:
- Regional dialogues supporting the implementation of Ukraine’s Affordable Medicines Program and improving access to reimbursed medicines across different regions.
- Progress toward the establishment of the Ukrainian Pharmaceutical Agency, a major step in strengthening medicines regulation and aligning Ukraine’s pharmaceutical system with international standards.
- A nationwide webinar on the VacBoard analytical dashboard, supporting stronger vaccine stock monitoring and data-driven decision-making.
- Educational webinars helping healthcare facilities strengthen the supply management of medicines and medical devices through better data use and inventory management.
- Regional discussions on the practical implementation of Managed Entry Agreements (MEAs) and expanding access to innovative medicines for patients with rare and complex conditions.
- A nationwide public health awareness campaign on HIV, tuberculosis, and viral hepatitis that reached millions of Ukrainians through healthcare facilities, public transportation, and digital channels.
Please find the full newsletter issues in English and Ukrainian, along with the success story.
Newsletter
Success Story – From data to action: How SAFEMed supports hospital decision-making in Ukraine
Our work in Ukraine aims to boost transparency, improve cost efficiency, and strengthen the pharmaceutical supply chain, ultimately leading to better availability and use of essential medicines and health commodities for TB, HIV and AIDS, COVID-19, and noncommunicable diseases. We support the Government of Ukraine in its ongoing efforts to reform its health care system in the wake of the war.